Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab
Clinical trial NCT02881567 · TERMINATED
Trial details
- NCT number
- NCT02881567
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2018-09-12
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.